Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies.

Althammer F, Muscatelli F, Grinevich V, Schaaf CP

Open source

DOI
10.1038/s41398-022-02054-1
Published
2022 Aug 8
Container
Translational psychiatry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41398-022-02054-1,
  title = {Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies.},
  author = {Althammer F and Muscatelli F and Grinevich V and Schaaf CP},
  year = {2022},
  journal = {Translational psychiatry},
  doi = {10.1038/s41398-022-02054-1},
  url = {https://doi.org/10.1038/s41398-022-02054-1}
}

RIS

TY  - JOUR
TI  - Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies.
AU  - Althammer F
AU  - Muscatelli F
AU  - Grinevich V
AU  - Schaaf CP
PY  - 2022
JO  - Translational psychiatry
DO  - 10.1038/s41398-022-02054-1
UR  - https://doi.org/10.1038/s41398-022-02054-1
ER  - 

APA

F, A., F, M., V, G., & CP, S. (2022). Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies.. Translational psychiatry. https://doi.org/10.1038/s41398-022-02054-1

Source records